EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dyslipidemia Fact Sheet in South Korea, 2022

Eun-Sun Jin, Jee-Seon Shim, Sung Eun Kim, Jae Hyun Bae, Shinae Kang, Jong Chul Won, Min-Jeong Shin, Heung Yong Jin, Jenny Moon, Hokyou Lee, Hyeon Chang Kim, In-Kyung Jeong

Diabetes & Metabolism Journal · 30.09.2023 · 47 (5) · 632-642

DOI: 10.4093/dmj.2023.0135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 30.09.2023. Verfasst von Eun-Sun Jin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea. Hauptthemen laut MEDLINE: Hypercholesterolemia, Dyslipidemias. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name Dyslipidemia Fact Sheet 2022.

Methods

We analyzed the lipid profiles, age-standardized and crude prevalence, management status of hypercholesterolemia and dyslipidemia, and health behaviors among Korean adults aged ≥20 years, using the Korea National Health and Nutrition Examination Survey data between 2007 and 2020.

Results

In South Korea, the crude prevalence of hypercholesterolemia (total cholesterol ≥240 mg/dL or use of a lipid-lowering drug) in 2020 was 24%, and the age-standardized prevalence of hypercholesterolemia more than doubled from 2007 to 2020. The crude treatment rate was 55.2%, and the control rate was 47.7%. The crude prevalence of dyslipidemia—more than one out of three conditions (low-density lipoprotein cholesterol ≥160 or the use of a lipid-lowering drug, triglycerides ≥200, or high-density lipoprotein cholesterol [HDL-C] [men and women]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaDyslipidemiasAdultMaleHumansFemaleNutrition SurveysRisk FactorsCholesterol, LDLRepublic of Korea

Stichwörter der Autor:innen

CholesterolDisease managementDyslipidemiasHealth behaviorPrevalenceRepublic of Korea

Substanzen

Cholesterol, LDL

Autor:innen und Institutionen

  • Department of Cardiology, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul, Korea.
  • Department of Preventive Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Division of Cardiology, Department of Internal Medicine, Kangdong Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, Korea.
  • Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Inje University Sanggye Paik Hospital, College of Medicine, Inje University, Seoul, Korea.

Zitieren

APA

Jin, E. S., Shim, J. S., Kim, S. E., Bae, J. H., Kang, S., Won, J. C., Shin, M. J., Jin, H. Y., Moon, J., Lee, H., Kim, H. C., & Jeong, I. K. (2023). Dyslipidemia Fact Sheet in South Korea, 2022. Diabetes & Metabolism Journal, 47(5), 632-642. https://doi.org/10.4093/dmj.2023.0135

Vancouver

Jin ES, Shim JS, Kim SE, Bae JH, Kang S, Won JC, et al. Dyslipidemia Fact Sheet in South Korea, 2022. Diabetes & Metabolism Journal. 2023;47(5):632-642. doi:10.4093/dmj.2023.0135

BibTeX
@article{Jin2023,
  author = {Jin, Eun-Sun and Shim, Jee-Seon and Kim, Sung Eun and Bae, Jae Hyun and Kang, Shinae and Won, Jong Chul and Shin, Min-Jeong and Jin, Heung Yong and Moon, Jenny and Lee, Hokyou and Kim, Hyeon Chang and Jeong, In-Kyung},
  title = {Dyslipidemia Fact Sheet in South Korea, 2022},
  journal = {Diabetes & Metabolism Journal},
  year = {2023},
  volume = {47},
  number = {5},
  pages = {632--642},
  doi = {10.4093/dmj.2023.0135}
}
Kostenlos starten →